Skip to content

Ultrasound-guided ilioabdominal ilioinguinal nerve block combined with lateral femoral cutaneous nerve block for postoperative analgesia after total hip replacement via direct anterior approach: a randomized controlled trial

Ultrasound-guided ilioabdominal ilioinguinal nerve block combined with lateral femoral cutaneous nerve block for postoperative analgesia after total hip replacement via direct anterior approach: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031040
Enrollment
Unknown
Registered
2020-03-21
Start date
2020-03-31
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

???????????

Interventions

Group A:Periarticular infiltration analgesia
Group B:Iliohypogastric/ilioinguinal nerve block, lateral femoral cutaneous nerve block and periarticular infiltration analgesia

Sponsors

Anaesthetic surgery center, West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients requiring primary total hip arthroplasty due to severe hip osteoarthritis, femoral head necrosis, and secondary osteoarthritis due to developmental hip dysplasia; 2. Aged between 18 and 80 years; 3. Patients with preoperative American Society of anesthesiologists (ASA) grading (anesthesia risk assessment) of I ~ III; 4. Patients with body mass index less than 30 kg / m2.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the drugs used in the experiment; 2. Patients with language disorders and inability to complete various questionnaire scores; 3. Patients with limb neuropathy on the operative side; 4. With mentally ill; 5. One-stage bilateral total hip arthroplasty; 6. With severe osteoporosis; 7. With a history of hip surgery prior to the initial replacement; 8. Patients with secondary osteoarthritis after treatment of hip infection; 9. Patients with iliac wing width or acetabulum posterior wall bone defect; 10. Alcoholic or long-term opioid users; 11. Patients with previous gastrointestinal ulcer.

Design outcomes

Primary

MeasureTime frame
Postoperative dosage of remedial morphine hydrochloride;Time of first postoperative analgesia;VAS pain score;QoR -15 scale;Quadriceps strength;Daily walking distance;Time to first straight leg raise;The duration of hospital stay;Incidence of postoperative complications;Oxford hip score;UCLA Activity-Level Rating;

Countries

China

Contacts

Public ContactJing Yang

West China Hospital of Sichuan University

1278788186@qq.com+86 13281896910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026